News
The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device that stores and transfers insulin dose-related data from the pen ...
Artificial intelligence is evolving at a breakneck pace – but not always to humans' benefit.
The artificial intelligence (AI) boom has investors wondering how they can benefit from what some experts believe is the next revolutionary technology. AI has the potential to dramatically change ...
This technology replaces syringes and vials, or prefilled insulin pen needles. These wearable devices are filled with enough insulin to last 2 to 4 days, and through a small cannula inserted just ...
Artificial untelligence (AI) stocks under $10 are publicly traded companies developing or applying AI technologies, with stock prices below $10 per share. These lower-priced AI stocks can present ...
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. One simple way to benefit from the stock market is to buy an index fund.
With type 2 diabetes, your body either doesn’t make enough insulin or doesn’t respond as usual to insulin. Your pancreas makes insulin. It’s a hormone that helps lower your blood sugar levels.
Dr. Brian Anderson of the Coalition for Health AI said there is "a real urgency" to ensure AI models are managed "robustly and appropriately." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results